cytena, a Freiburg, Germany-based developer of a device called cy-Clone to separate single cells, raised €1.1m in seed funding.
Backers included High-Tech Gründerfonds (HTGF) and a private investor.
The company intends to use the funds to launch its product and to expand its marketing and distribution activities.
Founded as a University of Freiburg spin-off by Jonas Schöndube, managing director, André Gross, technical director, along with the inventor of the technology Dr. Peter Koltay, economist Benjamin Steimle and BioFluidix GmbH, cytena develops the cy-Clone, a laboratory device that enables the separation of cells.
The cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies.
FinSMEs
03/05/2015